Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder

NCT00374543 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Recruitment goal could not be achieved

Conditions

Generalized Anxiety Disorder
Bipolar Disorder

Interventions

DRUG: Ziprasidone
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]